James Terwilliger

Stock Analyst at Northland Capital Markets

(n/a)
# 4,830
Out of 4,911 analysts
5
Total ratings
n/a
Success rate
-50.72%
Average return

Stocks Rated by James Terwilliger

InfuSystem Holdings
Apr 26, 2021
Initiates: Outperform
Price Target: $27
Current: $6.01
Upside: +349.25%
Zynex
Mar 9, 2021
Upgrades: Outperform
Price Target: n/a
Current: $2.58
Upside: -